DarioHealth Corp reports results for the quarter ended June 30 - Earnings Summary

• DarioHealth Corp DRIO.OQ reported a quarterly adjusted loss of 18 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -8 cents. The mean expectation of four analysts for the quarter was for a loss of 23 cents per share. Wall Street expected results to range from -31 cents to -18 cents per share.

• Revenue fell 14.2% to $5.37 million from a year ago; analysts expected $6.91 million.

• DarioHealth Corp's reported EPS for the quarter was a loss of 18 cents​.

• The company reported a quarterly loss of $18.56 million.

• DarioHealth Corp shares had fallen by 24.9% this quarter and lost 36.0% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 169.2% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

• Wall Street's median 12-month price target for DarioHealth Corp is $2.25, about 77.6% above its last closing price of $0.50

This summary was machine generated from LSEG data August 12 at 01:30 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)